🇺🇸 FDA
Pipeline program

Cell therapy

IOZ ChineseAS POI-2

Phase 1 gene_therapy active

Quick answer

Cell therapy for Primary Ovarian Insufficiency is a Phase 1 program (gene_therapy) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Primary Ovarian Insufficiency
Phase
Phase 1
Modality
gene_therapy
Status
active

Clinical trials